Pennant GroupPNTG +0.10%89 10-Year RORE % is 0.00 as of Mar. 2026. GuruFocus rates PNTG with a GF Score™ of 89/100 and a GF Value™ of $34.71 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 322 Healthcare Providers & Services companies, Pennant Group ranks worse than 310558.7% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Pennant Group does not have enough data to calculate 10-Year RORE %.
Pennant Group (NAS:PNTG) 10-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Pennant Group 10-Year RORE % Related Terms
Pennant Group 10-Year RORE % Historical Data
* Premium members only.
The historical data trend for Pennant Group's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PNTG vs AMN, NUTX, ARDT: 10-Year RORE % Comparison
For the Medical Care Facilities subindustry, Pennant Group's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pennant Group 10-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where Pennant Group's 10-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 10-year before.
Pennant Group (PNTG) has a 10-Year RORE % of 0.00 as of Mar. 2026. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Pennant Group and its competitors. According to the industry distribution chart, Pennant Group ranks #999999 out of 322 companies in the Healthcare Providers & Services industry.
Is Pennant Group's 10-Year RORE % too high?
Pennant Group's current 10-Year RORE % is 0.00. Based on the distribution chart, Pennant Group ranks #999999 out of 322 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pennant Group has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's 10-Year RORE % compare to AMN and NUTX?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #999999 out of 322 companies for 10-Year RORE %. This places Pennant Group in the lower half of its industry. The industry median 10-Year RORE % is 6.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year RORE % for a Healthcare Providers & Services company?
The median 10-Year RORE % among Healthcare Providers & Services companies is 6.25, based on 322 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year RORE % mean?
A high 10-Year RORE % can signal that a stock is expensive relative to its fundamentals. 10-Year RORE % shows how much a company earns by reinvesting its retained earnings in 10-year. View historical data on Pennant Group and its competitors. For the Healthcare Providers & Services industry, the median 10-Year RORE % is 6.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pennant Group's current 10-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $34.71, compared to a current price of $40.53 — trading 16.8% above its estimated fair value. The current 10-Year RORE % is 0.00. Pennant Group's overall GF Score™ is 89/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year RORE % calculated?
10-Year RORE % is calculated from a company's financial statements. For Pennant Group (PNTG), the current 10-Year RORE % is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pennant Group (PNTG) Overvalued in 2026?
Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued.
The current stock price of $40.53 is trading 16.8% above its estimated GF Value™ of $34.71.
GuruFocus considers Pennant Group to be Modestly Overvalued.
Key valuation signals for PNTG:
10-Year RORE %: 0.00
GF Value™: $34.71 vs. price of $40.53 (16.8% above fair value)
No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
89GF Score
Get the complete analysis for PNTG
10-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNTG has been successfully added to your 
